GPAtlas🧭 When to suspect
Suspect an adverse drug reaction (ADR) whenever a patient develops new or unexpected symptoms after starting a drug, increasing a dose, or taking an over-the-counter or herbal remedy.
• An ADR is an appreciably harmful or unpleasant reaction resulting from a medicinal product.
• Adverse drug reactions (ADRs) are a common and important cause of hospital admission.
• The presentation ranges from a mild rash or cough to a life-threatening emergency such as anaphylaxis or a severe cutaneous adverse reaction (SCAR).
The diagnostic anchor is a temporal relationship between the drug and symptom onset, supported where possible by:
• Improvement on stopping the drug (de-challenge).
• Recurrence on restarting it (re-challenge – rarely advisable in primary care).
Maintain a high index of suspicion in older patients on polypharmacy, in whom an ADR is easily mistaken for a new illness.
| Type | Nature | Example |
|---|---|---|
| A – Augmented | • Dose-related, predictable from pharmacology • Common (~80%), low mortality |
• Bradycardia with beta-blockers • Bleeding with anticoagulants • Hypoglycaemia with sulfonylureas |
| B – Bizarre | • Non-dose-related, unpredictable, uncommon • Higher mortality |
• Penicillin anaphylaxis • SJS/TEN • Idiosyncratic reactions |
| C – Chronic | Dose- and time-related (cumulative) | Adrenal suppression and osteoporosis with long-term corticosteroids |
| D – Delayed | • Time-related • May appear long after exposure, even after stopping |
• Teratogenesis • Tardive dyskinesia with antipsychotics • Secondary malignancy |
| E – End-of-use | Withdrawal reaction on stopping | • Benzodiazepine withdrawal • Rebound hypertension • Adrenal crisis on abrupt steroid cessation |
| F – Failure of therapy | Unexpected failure, often from an interaction | Reduced contraceptive efficacy with enzyme inducers (e.g. rifampicin, carbamazepine) |
The Rawlins–Thompson mnemonic – Augmented, Bizarre, Chronic, Delayed, End-of-use, Failure – is the classification used by the MHRA. The crucial split in practice is Type A (manage by reducing the dose) versus Type B (stop and avoid).
Source: MHRA
🔒 Sign up free to read the full topic
You're viewing a free preview. Create a free account to unlock the rest.
Sign up free →Sample topics are open to everyone in the Free Sample Bundle.